Literature DB >> 3968295

A comparison of dopamine, dobutamine and isoproterenol in the treatment of shock.

L I Worthley, P Tyler, J L Moran.   

Abstract

Twelve patients in shock, defined as being present if the mean arterial blood pressure was less than 60 mm Hg, pulmonary arterial occlusion pressure was 15 mm Hg or greater, urine output was 20 ml or less for 2 consecutive hours, and there was clinical evidence of poor peripheral perfusion, underwent a comparative therapeutic trial with dopamine at 200 micrograms . min-1 and 400 micrograms . min-1 (2.5-5.5 micrograms . kg-1 . min-1), dobutamine 250 micrograms . min-1 and 500 micrograms . min-1 (3.5-7 micrograms . kg-1 . min-1) and isoproterenol 2 micrograms . min-1 and 4 micrograms . min-1 (0.025-0.055 micrograms . kg-1 . min-1). Isoproterenol at 2 micrograms . min-1, produced a significant increase in pulse rate, cardiac output, left ventricular stroke work index and decrease in mean pulmonary blood pressure and pulmonary arterial occlusion pressure and at 4 micrograms . min-1 a significant increase in stroke volume, mixed venous oxygen tension and decrease in right atrial pressure and systemic vascular resistance was also observed. Dopamine at 200 micrograms . min-1 produced a significant increase in cardiac output, pulmonary arterial occlusion pressure and mixed venous oxygen tension and at 400 micrograms . min-1 a significant increase in pulse rate, mean arterial blood pressure mean pulmonary blood pressure, right ventricular stroke work index, right atrial pressure and pulmonary arterial occlusion pressure and decrease in arterial oxygen tension was also observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968295     DOI: 10.1007/bf00256059

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  28 in total

1.  Cardiovascular effects of isoproterenol in normal subjects and subjects with congestive heart failure.

Authors:  H T DODGE; J D LORD; H SANDLER
Journal:  Am Heart J       Date:  1960-07       Impact factor: 4.749

2.  Haemodynamic effects of dopamine in septic shock.

Authors:  B Regnier; M Rapin; G Gory; F Lemaire; B Teisseire; A Harari
Journal:  Intensive Care Med       Date:  1977-08       Impact factor: 17.440

3.  Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease.

Authors:  S L Meyer; G C Curry; M S Donsky; D B Twieg; R W Parkey; J T Willerson
Journal:  Am J Cardiol       Date:  1976-07       Impact factor: 2.778

4.  The effects of dopamine and isoproterenol on the pulmonary circulation.

Authors:  R M Mentzer; C A Alegre; S P Nolan
Journal:  J Thorac Cardiovasc Surg       Date:  1976-06       Impact factor: 5.209

Review 5.  Dopamine--clinical uses of an endogenous catecholamine.

Authors:  L I Goldberg
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

6.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

7.  The metabolic demand and oxygen supply of the heart: physiologic and clinical considerations.

Authors:  K T Weber; J S Janicki
Journal:  Am J Cardiol       Date:  1979-10       Impact factor: 2.778

8.  Ineffectiveness of isoproterenol in shock due to acute myocardial infarction.

Authors:  R M Gunnar; H S Loeb; R J Pietras; J R Tobin
Journal:  JAMA       Date:  1967-12-25       Impact factor: 56.272

9.  Transmural distribution of myocardial blood flow during systole in the awake dog.

Authors:  D S Hess; R J Bache
Journal:  Circ Res       Date:  1976-01       Impact factor: 17.367

10.  Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.

Authors:  C V Leier; P T Heban; P Huss; C A Bush; R P Lewis
Journal:  Circulation       Date:  1978-09       Impact factor: 29.690

View more
  5 in total

1.  Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia.

Authors:  C Szabó; G Haskó; B Zingarelli; Z H Németh; A L Salzman; V Kvetan; S M Pastores; E S Vizi
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

2.  Continuous multi-channel intravascular monitoring of the effects of dopamine and dobutamine on plasma potassium in dogs.

Authors:  H F Drake; M Smith; D R Corfield; T Treasure
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

3.  Adverse haemodynamic effects of sodium bicarbonate in metabolic acidosis.

Authors:  D J Cooper; L I Worthley
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

4.  The effects of dobutamine and dopamine on intrapulmonary shunt and gas exchange in healthy humans.

Authors:  Tracey L Bryan; Sean van Diepen; Mohit Bhutani; Miriam Shanks; Robert C Welsh; Michael K Stickland
Journal:  J Appl Physiol (1985)       Date:  2012-06-14

5.  Effects of two inotropic drugs, dopamine and dobutamine, on pulmonary gas exchange in artificially ventilated patients.

Authors:  M T Rennotte; M Reynaert; T Clerbaux; E Willems; J Roeseleer; C Veriter; D Rodenstein; A Frans
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.